13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001517796
Total reported value
$109.5M
$109.5M
72 檔
25.4%
During the Q2 2025 filing period, Rangeley Capital, LLC (CIK: 0001517796) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $109.5M across 72 reported positions.
During Q2 2025, Rangeley Capital, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics Inc | Stock-Other | 7.94% | — | +89.76% | |
| 2 | DK | Delek US Holdings Inc | Stock-Other | 7.91% | -1.38% | -7.67% | |
| 3 | ARVN | Arvinas Inc | Stock-Other | 6.10% | -0.98% | +27.96% | |
| 4 | CLMT | Calumet Inc | Stock-Other | 6.00% | -1.22% | -39.33% | |
| 5 | PRTA | Prothena Corporation plc | Stock-Other | 5.18% | -0.51% | — | |
| 6 | KROS | Keros Therapeutics Inc | Stock-Other | 4.55% | -0.05% | -30.09% | |
| 7 | SGRY | Surgery Partners Inc | Stock-Other | 4.40% | — | +82.68% | |
| 8 | CHTR | Charter Communications Inc-a | Stock-Comm Services | 4.39% | +0.58% | NEW | |
| 9 | WOW | Wideopenwest Inc | Stock-Other | 4.11% | — | +12.12% | |
| 10 | FLL | Full House Resorts Inc | Stock-Other | 3.85% | +0.36% | -0.75% | |
| 11 | 2662247D | Iteos Therapeutics Inc | Stock-Other | 3.59% | — | — | |
| 12 | SEG | Seaport Entertainment Group | Stock-Other | 3.52% | +0.53% | -3.95% | |
| 13 | ABUS | Arbutus Biopharma CORP | Stock-Other | 3.19% | — | -35.88% | |
| 14 | CORZW | Core Scientific Inc - 27 | Stock-Other | 2.98% | +0.27% | — | |
| 15 | NLOP | Net Lease Office Property | Stock-Other | 2.72% | -0.32% | -36.40% | |
| 16 | SKAA | Skechers USA Inc-cl A | Stock-Other | 2.71% | — | — | |
| 17 | ✓ | Third Harmonic Bio Inc | Stock-Other | 1.88% | — | +7.41% | |
| 18 | CDZI | Cadiz Inc | Stock-Other | 1.67% | -0.05% | -25.56% | |
| 19 | STHO | Star Holdings | Stock-Other | 1.60% | +0.69% | +33.33% | |
| 20 | UAN | Cvr Partners LP | Stock-Other | 1.59% | — | -35.30% | |
| 21 | GEL | Genesis Energy L.p. | Stock-Other | 1.52% | — | -60.85% | |
| 22 | WBA | Walgreens Boots Alliance Inc | Stock-Other | 1.40% | — | — | |
| 23 | NRP | Natural Resource Partners LP | Stock-Other | 1.38% | — | — | |
| 24 | AMPY | Amplify Energy CORP | Stock-Other | 1.07% | — | -75.00% | |
| 25 | BUR | Burford Capital Limited | Stock-Other | 0.87% | -0.05% | EXIT | |
| 26 | ✓ | Verve Therapeutics Inc | Stock-Other | 0.83% | — | — | |
| 27 | KURA | Kura Oncology Inc | Stock-Other | 0.80% | +0.14% | — | |
| 28 | LNSR | Lensar Inc | Stock-Other | 0.79% | -0.36% | EXIT | |
| 29 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.76% | — | — | |
| 30 | SEPN | Septerna Inc | Stock-Other | 0.74% | -0.71% | +10.68% | |
| 31 | SWKH | Swk Holdings CORP | Stock-Other | 0.72% | -1.04% | EXIT | |
| 32 | SOC | Sable Offshore CORP | Stock-Other | 0.66% | -0.25% | — | |
| 33 | HEPS | D-market Electronic Serv-adr | Stock-Other | 0.64% | +0.02% | +38.58% | |
| 34 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.64% | — | — | |
| 35 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.62% | -0.07% | — | |
| 36 | RPTX | Repare Therapeutics Inc | Stock-Other | 0.59% | — | — | |
| 37 | SITC | Site Centers CORP | Stock-Other | 0.54% | -0.02% | +227.96% | |
| 38 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 0.44% | -0.07% | — | |
| 39 | ✓ | Elevation Oncology Inc | Stock-Other | 0.40% | — | — | |
| 40 | ✓ | Mountain Lake Acquisition Co | Stock-Other | 0.37% | — | -62.50% | |
| 41 | ✓ | Hillevax Inc | Stock-Other | 0.37% | — | — | |
| 42 | EPIEUR | Essa Pharma Inc | Stock-Other | 0.34% | — | — | |
| 43 | GME | GameStop Corp. | Stock-Consumer Disc | 0.32% | — | +19.31% | |
| 44 | KEL | Kellanova | Stock-Other | 0.28% | — | — | |
| 45 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.26% | — | -72.22% | |
| 46 | NBIS | Nebius Group N.V. | Stock-Other | 0.26% | — | -60.61% | |
| 47 | ✓ | Stock-Other | 0.25% | — | — | ||
| 48 | 75Z | Soho House & Co Inc | Stock-Other | 0.24% | — | -22.33% | |
| 49 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.23% | -0.06% | — | |
| 50 | CRGX | Cargo Therapeutics Inc | Stock-Other | 0.21% | — | -48.87% |
According to official SEC Form 13F filings, Rangeley Capital, LLC reported a total U.S. public equity portfolio value of $109.5M across 72 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SG7, DK, ARVN) accounted for 25.4% of total reported equity market value during Q2 2025.
During Q2 2025, Rangeley Capital, LLC's top holdings by market value included SG7 (7.9%)、DK (7.9%)、ARVN (6.1%). The largest single position, SG7, represented 7.9% of total portfolio value.
In Q2 2025, Rangeley Capital, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.